Related references
Note: Only part of the references are listed.Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods
Apoorva M. Kulkarni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation
Navanath Kumbhar et al.
SCIENTIFIC REPORTS (2022)
CCL5/CCR5 axis in human diseases and related treatments
Zhen Zeng et al.
GENES & DISEASES (2022)
Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds
Neha Murad et al.
DRUG METABOLISM AND DISPOSITION (2021)
A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment
Raj Kumar et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks et al.
NATURE MEDICINE (2021)
Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein
Firoz A. Dain Md Opo et al.
SCIENTIFIC REPORTS (2021)
In silico prediction of volume of distribution of drugs in man using conformal prediction performs on par with animal data-based models
Urban Fagerholm et al.
XENOBIOTICA (2021)
Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics
Shraddha Parate et al.
RSC ADVANCES (2021)
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics
Shraddha Parate et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Identification of ACK1 inhibitors as anticancer agents by using computer-aided drug designing
Vikas Kumar et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
Hui Zhang et al.
NATURE COMMUNICATIONS (2021)
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
Vikas Kumar et al.
BIOMEDICINES (2021)
Elimination of bitter-off taste of stevioside through structure modification and computational interventions
Vijay Bhardwaj et al.
JOURNAL OF THEORETICAL BIOLOGY (2020)
Application of MM-PBSA Methods in Virtual Screening
Giulio Poli et al.
MOLECULES (2020)
Advances of CCR5 antagonists: From small molecules to macromolecules
Baowen Qi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1-Ligand Binding Free Energy Calculation
Eko Aditya Rifai et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
Sourav Pal et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Molecular dynamics simulations and novel drug discovery
Xuewei Liu et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Recent Developments and Applications of the MMPBSA Method
Changhao Wang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
In silico ADME-Tox modeling: progress and prospects
Saeed Alqahtani
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV
Yi Zheng et al.
IMMUNITY (2017)
The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV infection
Assunta Venuti et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1
Yue Tan et al.
FRONTIERS IN IMMUNOLOGY (2017)
P-glycoprotein and its role in drug-drug interactions
Andrew Finch et al.
Australian Prescriber (2016)
Molecular dynamics analysis to evaluate docking pose prediction
Takako Sakano et al.
BIOPHYSICS AND PHYSICOBIOLOGY (2016)
Therapy of HIV Infection: Current Approaches and Prospects
M. M. Prokofjeva et al.
ACTA NATURAE (2016)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Establishment of a screening protocol for identification of aminopeptidase N inhibitors
Miaomiao Niu et al.
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS (2015)
Molecular Docking and Structure-Based Drug Design Strategies
Leonardo G. Ferreira et al.
MOLECULES (2015)
Investigation of Inhibition Mechanism of Chemokine Receptor CCR5 by Micro-second Molecular Dynamics Simulations
Ramin Ekhteiari Salmas et al.
SCIENTIFIC REPORTS (2015)
GMXPBSA 2.1: A GROMACS tool to perform MM/PBSA and computational alanine scanning
C. Paissoni et al.
COMPUTER PHYSICS COMMUNICATIONS (2014)
Anti-HIV Drug Development Through Computational Methods
Wan-Gang Gu et al.
AAPS JOURNAL (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
PubChem BioAssay: 2014 update
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
Mahreen Arooj et al.
PLOS ONE (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
P-glycoprotein Inhibition for Optimal Drug Delivery
Md. Lutful Amin
DRUG TARGET INSIGHTS (2013)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study
Gugan Kothandan et al.
PLOS ONE (2012)
Combination of the CHARMM27 Force Field with United-Atom Lipid Force Fields
Nicolas Sapay et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Molecular dynamics simulations of protein dynamics and their relevance to drug discovery
Freddie R. Salsbury
CURRENT OPINION IN PHARMACOLOGY (2010)
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Sheng-Yong Yang
DRUG DISCOVERY TODAY (2010)
A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors
Legesse Adane et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2010)
Revealing Noncovalent Interactions
Erin R. Johnson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
HIV Entry Inhibitors and Their Potential in HIV Therapy
Keduo Qian et al.
MEDICINAL RESEARCH REVIEWS (2009)
HIV entry in macrophages is dependent on intact lipid rafts
Gemma C. Carter et al.
VIROLOGY (2009)
The biology of CCR5 and CXCR4
Ghalib Alkhatib
CURRENT OPINION IN HIV AND AIDS (2009)
Chemokines and their receptors: Drug targets in immunity and inflammation
Antonella Viola et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Canonical sampling through velocity rescaling
Giovanni Bussi et al.
JOURNAL OF CHEMICAL PHYSICS (2007)
CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism
C. R. Shideman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults
J Lalezari et al.
AIDS (2005)
Chemokine receptor CCR5: insights into structure, function, and regulation
M Oppermann
CELLULAR SIGNALLING (2004)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Pathways for internalization and recycling of the chemokine receptor CCR5
A Mueller et al.
BLOOD (2002)
Prediction of drug absorption using multivariate statistics
WJ Egan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
β-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk
RK Ganju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
